HIV

[Steven Specter]

There is experimentation continuing with interleukin 2.  Some results 
were reported at the AIDS meeting in Washington that took 
place January/February 1995.  Results suggested that low dose or 
intermittent IL-2 along with AZT showed greater benefit than AZT alone.  
These results must be tempered by the fact that the study is still 
relatively short term but they are hopeful.  I believe this work was 
reported by Dr. Clifford Lane who is an NIH scientist.

On 19 May 1995 sid at usa1.com wrote:

> 	I was wondering if there was any new information regarding treatment w/people who have 
> HIV with Interluekin II?
> 
> 
>